All Stories

  1. The Effects of Long-Term High Fat and/or High Sugar Feeding on Sources of Postprandial Hepatic Glycogen and Triglyceride Synthesis in Mice

    Article • Nutrients, July 2024, MDPI AG

    Dr Amalia Gastaldelli

  2. Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies

    Article • Metabolism, June 2024, Elsevier

    Dr Amalia Gastaldelli

  3. Differential effect of endogenous glucagon‐like peptide‐1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery

    Article • Diabetes Obesity and Metabolism, April 2024, Wiley

    Dr Amalia Gastaldelli

  4. Clusters of adipose tissue dysfunction in adults with type 2 diabetes identify those with worse lipidomic profile despite similar glycaemic control

    Article • Diabetes/Metabolism Research and Reviews, April 2024, Wiley

    Dr Amalia Gastaldelli

  5. Vagal activation alters prandial bile acid composition and glycemia in patients with hypoglycemia after Roux‐en‐Y gastric bypass surgery

    Article • Neurogastroenterology & Motility, February 2024, Wiley

    Dr Amalia Gastaldelli

  6. Hepatic glucose metabolism in the steatotic liver

    Article • Nature Reviews Gastroenterology & Hepatology, February 2024, Springer Science + Business Media

    Dr Amalia Gastaldelli

  7. Methods to Study Metabolomics

    Article • January 2024, Springer Science + Business Media

    Dr Amalia Gastaldelli

  8. ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model

    Article • Gut, December 2023, BMJ

    Dr Amalia Gastaldelli

  9. Reflecting on a Year at the Helm of Diabetes Care

    Article • Diabetes Care, December 2023, American Diabetes Association

    Dr Amalia Gastaldelli

  10. Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives

    Article • Journal of Hepatology, November 2023, Elsevier

    Dr Amalia Gastaldelli

  11. Reduced Insulin Clearance Differently Relates to Increased Liver Lipid Content and Worse Glycemic Control in Recent-Onset Type 2 and Type 1 Diabetes

    Article • Diabetes Care, October 2023, American Diabetes Association

    Dr Amalia Gastaldelli

  12. GLP-1 enhances beta-cell response to protein ingestion independent of glycemia and bariatric surgery amplifies it

    Article • October 2023, Cold Spring Harbor Laboratory Press

    Dr Amalia Gastaldelli

  13. Differential effect of gastric bypass versus sleeve gastrectomy on insulinotropic action of endogenous incretins

    Article • Obesity, October 2023, Wiley

    Dr Amalia Gastaldelli

  14. Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk

    Article • International Journal of Molecular Sciences, September 2023, MDPI AG

    Dr Amalia Gastaldelli

  15. Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective

    Article • Journal of Clinical Medicine, September 2023, MDPI AG

    Dr Amalia Gastaldelli

  16. Endogenous glucagon-like peptide 1 diminishes prandial glucose counterregulatory response to hypoglycemia after gastric bypass surgery

    Article • September 2023, Cold Spring Harbor Laboratory Press

    Dr Amalia Gastaldelli

  17. Exposure profiles in pregnant women from a birth cohort in a highly contaminated area of southern Italy

    Article • Scientific Reports, September 2023, Springer Science + Business Media

    Dr Amalia Gastaldelli

  18. Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study

    Article • Metabolites, August 2023, MDPI AG

    Dr Amalia Gastaldelli

  19. A global action agenda for turning the tide on fatty liver disease

    Article • Hepatology, August 2023, Wolters Kluwer Health

    Professor Yousef Khader, Dr Amalia Gastaldelli

  20. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    Article • The Lancet Gastroenterology & Hepatology, August 2023, Elsevier

    Dr Amalia Gastaldelli

  21. Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2023, Endocrine Society

    Dr Amalia Gastaldelli

  22. Bariatric Surgery Alters the Postprandial Recovery From Hypoglycemia, Mediated by Cholinergic Signal

    Article • Diabetes, July 2023, American Diabetes Association

    Dr Amalia Gastaldelli

  23. Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!

    Article • Diabetes Care, June 2023, American Diabetes Association

    Dr Amalia Gastaldelli

  24. Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts

    Article • Diabetologia, June 2023, Springer Science + Business Media

    Dr Amalia Gastaldelli

  25. A global research priority agenda to advance public health responses to fatty liver disease

    Article • Journal of Hepatology, June 2023, Elsevier

    Dr Mona H. Ismail, Professor Yousef Khader, Dr Amalia Gastaldelli

  26. Lipidomic Profiling Unveils Sex Differences in Diabetes Risk: Implications for Precision Medicine

    Article • May 2023, Cold Spring Harbor Laboratory Press

    Dr Amalia Gastaldelli

  27. Plasma Amino Acids in NAFLD Patients With Obesity Are Associated With Steatosis and Fibrosis; Results From the MAST4HEALTH Study

    Article • April 2023, MDPI AG

    Dr Amalia Gastaldelli

  28. Role of Insulin Clearance in Insulin Action and Metabolic Diseases

    Article • International Journal of Molecular Sciences, April 2023, MDPI AG

    Dr Amalia Gastaldelli

  29. Insulinotropic effect of endogenous incretins is greater after gastric bypass than sleeve gastrectomy despite diminished beta-cell sensitivity to plasma incretins

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Dr Amalia Gastaldelli

  30. Insulin Clearance in Health and Disease

    Article • Annual Review of Physiology, February 2023, Annual Reviews

    Dr Amalia Gastaldelli

  31. Brain histone beta-hydroxybutyrylation couples metabolism with gene expression

    Article • Cellular and Molecular Life Sciences, January 2023, Springer Science + Business Media

    Dr Amalia Gastaldelli

  32. Higher Hepatic Glucose Production and Gluconeogenesis are Features of Severe Metabolic Dysfunction-Associated Steatohepatitis Even in Absence of T2D

    Article • January 2023, Elsevier

    Dr Amalia Gastaldelli

  33. Responses to Lifestyle Intervention in Individuals at High Risk of Type 2 Diabetes Depend on Pre-Intervention Insulin Sensitivity and Secretion: A Machine Learning Analysis of DEXLIFE and EGIR-RISC Data

    Article • January 2023, Elsevier

    Dr Amalia Gastaldelli

  34. “The Times They Are A-Changin’” at Diabetes Care

    Article • Diabetes Care, December 2022, American Diabetes Association

    Dr Amalia Gastaldelli

  35. Exposure to Endocrine Disruptors (Di(2-Ethylhexyl)phthalate (DEHP) and Bisphenol A (BPA)) in Women from Different Residing Areas in Italy: Data from the LIFE PERSUADED Project

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Dr Amalia Gastaldelli

  36. Exposure profiles in pregnant women from a birth cohort in a highly contaminated area of southern Italy

    Article • November 2022, Cold Spring Harbor Laboratory Press

    Dr Amalia Gastaldelli

  37. Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes

    Article • Diabetes Obesity and Metabolism, November 2022, Wiley

    Dr Amalia Gastaldelli

  38. Enrichment of hepatic glycogen and plasma glucose from H₂18O informs gluconeogenic and indirect pathway fluxes in naturally feeding mice

    Article • NMR in Biomedicine, October 2022, Wiley

    Dr Amalia Gastaldelli

  39. Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes

    Article • Diabetes & Metabolism, September 2022, Elsevier

    Dr Amalia Gastaldelli

  40. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals

    Article • Liver International, August 2022, Wiley

    Dr Amalia Gastaldelli

  41. Measuring and estimating insulin resistance in clinical and research settings

    Article • Obesity, July 2022, Wiley

    Dr Amalia Gastaldelli

  42. High exposure to phthalates is associated with HbA1c worsening in type 2 diabetes subjects with and without edentulism: a prospective pilot study

    Article • Diabetology & Metabolic Syndrome, July 2022, Springer Science + Business Media

    Dr Amalia Gastaldelli

  43. Altered Insulin Clearance after Gastric Bypass and Sleeve Gastrectomy in the Fasting and Prandial Conditions

    Article • International Journal of Molecular Sciences, July 2022, MDPI AG

    Dr Amalia Gastaldelli

  44. Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial

    Article • The Lancet Diabetes & Endocrinology, June 2022, Elsevier

    Dr Amalia Gastaldelli

  45. 360-OR: Hyperglucagonemia Reduces De Novo Lipogenesis and Increases Gluconeogenesis in Healthy Subjects

    Article • Diabetes, June 2022, American Diabetes Association

    Dr Amalia Gastaldelli

  46. Is it necessary to target lipid metabolism in different organs for effective treatment of NASH?—the results of the Pan-PPAR Lanifibranor trial

    Article • HepatoBiliary Surgery and Nutrition, June 2022, AME Publishing Company

    Dr Amalia Gastaldelli

  47. 1298-P: Metabolic Clearance of Insulin Is Altered after Gastric Bypass and Sleeve Gastrectomy

    Article • Diabetes, June 2022, American Diabetes Association

    Dr Amalia Gastaldelli

  48. Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy

    Article • Metabolism, June 2022, Elsevier

    Dr Amalia Gastaldelli

  49. 57-OR: Responses to Lifestyle Intervention (LI) Are Associated to the Inter-Individual Variability in Glucose Metabolism at Baseline for Individuals at High Risk of Type 2 Diabetes (T2D)

    Article • Diabetes, June 2022, American Diabetes Association

    Dr Amalia Gastaldelli

  50. Women exposure to Di(2-ethylhexyl)phthalate (DEHP) and bisphenol A (BPA) from different residing areas in Italy: data from the LIFE PERSUADED project

    Article • May 2022, Cold Spring Harbor Laboratory Press

    Dr Amalia Gastaldelli

  51. Global multi-stakeholder endorsement of the MAFLD definition

    Article • The Lancet Gastroenterology & Hepatology, May 2022, Elsevier

    Dr Feliciano C Paquissi, Professor Sandro Vento, Dr. Francesca Cainelli, Prof. Dr. Mahmoud ElFiky, Dr Arif Mansur Cosar, Dr Amalia Gastaldelli

  52. Advanced glycation end products, leukocyte telomere length, and mitochondrial DNA copy number in patients with coronary artery disease and alterations of glucose homeostasis: From the GENOCOR study

    Article • Nutrition Metabolism and Cardiovascular Diseases, May 2022, Elsevier

    Dr Amalia Gastaldelli

  53. Editorial: Mechanisms for the Alteration in the Crosstalk Among Insulin-Sensitive Tissues

    Article • Frontiers in Endocrinology, April 2022, Frontiers

    Dr Amalia Gastaldelli

  54. Insulin: The master regulator of glucose metabolism

    Article • Metabolism, April 2022, Elsevier

    Dr Amalia Gastaldelli

  55. Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose

    Article • Diabetes Care, March 2022, American Diabetes Association

    Dr Amalia Gastaldelli

  56. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

    Article • Journal of Hepatology, March 2022, Elsevier

    Sami Qadri, Dr Amalia Gastaldelli

  57. Autoantibodies against the glial glutamate transporter GLT1/EAAT2 in Type 1 diabetes mellitus—Clues to novel immunological and non-immunological therapies

    Article • Pharmacological Research, March 2022, Elsevier

    Dr Amalia Gastaldelli

  58. Assessment of Exposure to Di-(2-ethylhexyl) Phthalate (DEHP) Metabolites and Bisphenol A (BPA) and Its Importance for the Prevention of Cardiometabolic Diseases

    Article • Metabolites, February 2022, MDPI AG

    Dr Amalia Gastaldelli

  59. Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes ( EDICT )

    Article • Diabetes Obesity and Metabolism, February 2022, Wiley

    Dr Amalia Gastaldelli

  60. Metabolic dysfunction-associated fatty liver disease: a year in review

    Article • Current Opinion in Gastroenterology, February 2022, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  61. Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease

    Article • Journal of Clinical Medicine, January 2022, MDPI AG

    Dr Amalia Gastaldelli

  62. Adipose tissue dysfunction and visceral fat are associated to hepatic insulin resistance and severity of NASH even in lean individuals

    Article • January 2022, Cold Spring Harbor Laboratory Press

    Dr Amalia Gastaldelli

  63. Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study

    Article • International Journal of Environmental Research and Public Health, January 2022, MDPI AG

    Dr Amalia Gastaldelli

  64. Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction

    Article • January 2022, Springer Science + Business Media

    Dr Amalia Gastaldelli

  65. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models

    Article • Cellular and Molecular Gastroenterology and Hepatology, January 2022, Elsevier

    Dr Amalia Gastaldelli

  66. Why does obesity cause diabetes?

    Article • Cell Metabolism, January 2022, Elsevier

    Dr Amalia Gastaldelli

  67. Women Exposure to Di(2-Ethylhexyl)Phthalate (Dehp) and Bisphenol a (Bpa) from Different Residing Areas in Italy: Data from the Life Persuaded Project

    Article • SSRN Electronic Journal, January 2022, Elsevier

    Dr Amalia Gastaldelli

  68. Metabolite Changes After Metabolic Surgery – Associations to Parameters Reflecting Glucose Homeostasis and Lipid Levels

    Article • Frontiers in Endocrinology, December 2021, Frontiers

    Dr Amalia Gastaldelli

  69. Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non‐alcoholic steatohepatitis

    Article • European Journal of Clinical Investigation, December 2021, Wiley

    Dr Amalia Gastaldelli

  70. Assessment of exposure to Di (2-ethylhexyl) phthalate (DEHP) metabolites and Bisphenol A (BPA) and its importance for the prevention of cardiometabolic diseases

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Dr Amalia Gastaldelli

  71. Disparity-filtered differential correlation network analysis: a case study on CRC metabolomics

    Article • Journal of Integrative Bioinformatics, November 2021, De Gruyter

    Dr Amalia Gastaldelli

  72. Italian Children Exposure to Bisphenol A: Biomonitoring Data from the LIFE PERSUADED Project

    Article • International Journal of Environmental Research and Public Health, November 2021, MDPI AG

    Dr Amalia Gastaldelli

  73. Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma

    Article • Minerva Endocrinology, October 2021, Edizioni Minerva Medica

    Dr Amalia Gastaldelli

  74. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    Article • Journal of Hepatology, October 2021, Elsevier

    Dr Amalia Gastaldelli

  75. An extra virgin olive oil‐enriched chocolate spread positively modulates insulin‐resistance markers compared with a palm oil‐enriched one in healthy young adults: A double‐blind, cross‐over, randomised controlled trial

    Article • Diabetes/Metabolism Research and Reviews, September 2021, Wiley

    Dr Amalia Gastaldelli

  76. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

    Article • Nature Reviews Gastroenterology & Hepatology, September 2021, Springer Science + Business Media

    Dr Amalia Gastaldelli

  77. Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action

    Article • Pharmacological Research, September 2021, Elsevier

    Dr Amalia Gastaldelli

  78. New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms

    Article • Diabetes Care, August 2021, American Diabetes Association

    Roberto Bizzotto, Dr Amalia Gastaldelli

  79. Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial

    Article • Diabetes Research and Clinical Practice, August 2021, Elsevier

    Dr Amalia Gastaldelli

  80. PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH

    Article • Liver International, July 2021, Wiley

    Dr Amalia Gastaldelli

  81. 125-LB: Differential Influences of Gastric Bypass and Sleeve Gastrectomy on Glucose-Reducing Effects of DPP-4 Inhibitor

    Article • Diabetes, June 2021, American Diabetes Association

    Dr Amalia Gastaldelli

  82. 215-LB: The Role of GLP-1 in Glycemic Response to Protein Ingestion after Gastric Bypass Surgery or Sleeve Gastrectomy

    Article • Diabetes, June 2021, American Diabetes Association

    Dr Amalia Gastaldelli

  83. Changes in Plasma Bioactive Lipids and Inflammatory Markers during a Half-Marathon in Trained Athletes

    Article • Applied Sciences, May 2021, MDPI AG

    Dr Amalia Gastaldelli

  84. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

    Article • Gut, May 2021, BMJ

    Dr Amalia Gastaldelli

  85. Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD

    Article • Frontiers in Immunology, May 2021, Frontiers

    Dr Amalia Gastaldelli

  86. Comment on Piccinini and Bergman. The Measurement of Insulin Clearance. Diabetes Care 2020;43:2296–2302

    Article • Diabetes Care, May 2021, American Diabetes Association

    Dr Amalia Gastaldelli

  87. Toxicological Assessment of Oral Co-Exposure to Bisphenol A (BPA) and Bis(2-ethylhexyl) Phthalate (DEHP) in Juvenile Rats at Environmentally Relevant Dose Levels: Evaluation of the Synergic, Additive or Antagonistic Effects

    Article • International Journal of Environmental Research and Public Health, April 2021, MDPI AG

    Dr Amalia Gastaldelli

  88. Liver-targeting drugs and their effect on blood glucose and hepatic lipids

    Article • Diabetologia, April 2021, Springer Science + Business Media

    Dr Amalia Gastaldelli

  89. TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models

    Article • Digestive and Liver Disease, March 2021, Elsevier

    Dr Amalia Gastaldelli

  90. Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial

    Article • Molecular Nutrition & Food Research, February 2021, Wiley

    Dr Amalia Gastaldelli

  91. External Validation of Surrogate Indices of Fatty Liver in the General Population: The Bagnacavallo Study

    Article • Journal of Clinical Medicine, February 2021, MDPI AG

    Dr Amalia Gastaldelli

  92. Metabolic, reproductive and thyroid effects of bis(2-ethylhexyl) phthalate (DEHP) orally administered to male and female juvenile rats at dose levels derived from children biomonitoring study

    Article • Toxicology, February 2021, Elsevier

    Dr Amalia Gastaldelli

  93. Krill Oil Supplementation Reduces Exacerbated Hepatic Steatosis Induced by Thermoneutral Housing in Mice with Diet-Induced Obesity

    Article • Nutrients, January 2021, MDPI AG

    Dr Amalia Gastaldelli

  94. SGLT2 inhibitors and thiazide enhance excretion of DEHP toxic metabolites in subjects with type 2 diabetes: A randomized clinical trial

    Article • Environmental Research, January 2021, Elsevier

    Dr Amalia Gastaldelli

  95. Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition

    Article • Diabetes Care, December 2020, American Diabetes Association

    Michael Krebs, Dr Amalia Gastaldelli

  96. TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models

    Article • December 2020, Cold Spring Harbor Laboratory Press

    Dr Amalia Gastaldelli

  97. The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes

    Article • Current Opinion in Pharmacology, December 2020, Elsevier

    Dr Amalia Gastaldelli

  98. Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P

    Article • International Journal of Molecular Sciences, November 2020, MDPI AG

    Dr Amalia Gastaldelli

  99. Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance

    Article • Diabetes, October 2020, American Diabetes Association

    Dr Amalia Gastaldelli

  100. COVID-19 Infection Pandemic: From the Frontline in Italy

    Article • Journal of the American College of Nutrition, October 2020, Taylor & Francis

    Dr Amalia Gastaldelli

  101. Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects

    Article • Diabetes, October 2020, American Diabetes Association

    Dr Amalia Gastaldelli

  102. Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase

    Article • International Journal of Molecular Sciences, September 2020, MDPI AG

    Dr Amalia Gastaldelli

  103. Small intestinal metabolism is central to whole-body insulin resistance

    Article • Gut, September 2020, BMJ

    Dr Amalia Gastaldelli

  104. Effects of Probiotic Supplementation on Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial

    Article • Frontiers in Psychiatry, September 2020, Frontiers

    Dr Amalia Gastaldelli

  105. The Pro12Ala polymorphism of PPARγ2 modulates beta cell function and failure to oral glucose‐lowering drugs in patients with type 2 diabetes

    Article • Diabetes/Metabolism Research and Reviews, September 2020, Wiley

    Dr Amalia Gastaldelli

  106. Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH

    Article • International Journal of Molecular Sciences, August 2020, MDPI AG

    Dr Amalia Gastaldelli

  107. Mechanisms for increased risk of diabetes in chronic liver diseases

    Article • Liver International, July 2020, Wiley

    Dr Amalia Gastaldelli

  108. Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?

    Article • Annals of Hepatology, July 2020, Elsevier

    Dr Amalia Gastaldelli

  109. Relationship between hepatic and systemic angiopoietin‐like 3, hepatic Vitamin D receptor expression and NAFLD in obesity

    Article • Liver International, June 2020, Wiley

    Dr Amalia Gastaldelli

  110. 153-OR: Glucose-Dependency of Insulinotropic and Glucagonostatic Effects of Glucagon-Like Peptide-1 after Gastric Bypass and Sleeve Gastrectomy

    Article • Diabetes, June 2020, American Diabetes Association

    Dr Amalia Gastaldelli

  111. 1774-P: Neurally Mediated Prandial Islet-Cell Function Is Glucose-Independent and Preserved after Gastric Bypass and Sleeve Gastrectomy

    Article • Diabetes, June 2020, American Diabetes Association

    Dr Amalia Gastaldelli

  112. 1836-P: Nonalcoholic Steatohepatitis (NASH) Significantly Contribute to ß-Cell Function Impairment Independently of Glucose Tolerance Status

    Article • Diabetes, June 2020, American Diabetes Association

    Dr Amalia Gastaldelli

  113. 352-OR: Combination Therapy with Dapagliflozin plus Exenatide on Endogenous Glucose Production: A Mechanism of Action Study

    Article • Diabetes, June 2020, American Diabetes Association

    Dr Amalia Gastaldelli

  114. Biomonitoring of Bis(2-ethylhexyl)phthalate (DEHP) in Italian children and adolescents: Data from LIFE PERSUADED project

    Article • Environmental Research, June 2020, Elsevier

    Dr Amalia Gastaldelli

  115. The PNPLA3‐I148M variant increases polyunsaturated triglycerides in human adipose tissue

    Article • Liver International, May 2020, Wiley

    Sami Qadri, Dr Amalia Gastaldelli

  116. Insulin sensitivity depends on the route of glucose administration

    Article • Diabetologia, May 2020, Springer Science + Business Media

    Dr Amalia Gastaldelli

  117. Biomarkers of exposure and early effect in three contaminated sites of southern Italy: protocols for etiological epidemiological studies

    Article • BMJ Open, May 2020, BMJ

    Dr Liliana LC Cori, Dr Amalia Gastaldelli

  118. Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk

    Article • Journal of Human Hypertension, April 2020, Springer Science + Business Media

    Dr Amalia Gastaldelli

  119. Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study

    Article • Journal of Clinical Medicine, April 2020, MDPI AG

    Dr Amalia Gastaldelli

  120. Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease

    Article • JCI Insight, March 2020, American Society for Clinical Investigation

    Dr Amalia Gastaldelli

  121. Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion

    Article • Diabetes Care, March 2020, American Diabetes Association

    Dr Amalia Gastaldelli

  122. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications

    Article • BMJ Open Diabetes Research & Care, February 2020, BMJ

    Gianluca Perseghin, Dr Amalia Gastaldelli

  123. Fatty liver, cardiometabolic disease and mortality

    Article • Current Opinion in Lipidology, February 2020, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  124. Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD

    Article • Journal of Endocrinological Investigation, February 2020, Springer Science + Business Media

    Dr Amalia Gastaldelli

  125. Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, February 2020, Elsevier

    Dr Amalia Gastaldelli

  126. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes

    Article • EBioMedicine, February 2020, Elsevier

    Dr Amalia Gastaldelli

  127. Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects

    Article • American Journal of Clinical Nutrition, February 2020, Elsevier

    Dr Amalia Gastaldelli

  128. Healthy aging: the INTECMAN project

    Article • Aging Clinical and Experimental Research, January 2020, Springer Science + Business Media

    Dr Amalia Gastaldelli

  129. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity

    Article • Endocrine, December 2019, Springer Science + Business Media

    Dr Amalia Gastaldelli

  130. Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease

    Article • International Journal of Molecular Sciences, December 2019, MDPI AG

    Dr Amalia Gastaldelli

  131. Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes

    Article • Diabetes Obesity and Metabolism, December 2019, Wiley

    Dr Amalia Gastaldelli

  132. Inflammatory Biomarkers are Correlated with Some Forms of Regressive Autism Spectrum Disorder

    Article • Brain Sciences, December 2019, MDPI AG

    Dr Amalia Gastaldelli

  133. Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A “non-invasive alternative” to liver biopsy?

    Article • Metabolism, December 2019, Elsevier

    Dr Amalia Gastaldelli

  134. Juvenile Toxicity Rodent Model to Study Toxicological Effects of Bisphenol A (BPA) at Dose Levels Derived From Italian Children Biomonitoring Study

    Article • Toxicological Sciences, November 2019, Oxford University Press (OUP)

    Dr Amalia Gastaldelli

  135. Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis

    Article • Diabetologia, November 2019, Springer Science + Business Media

    Dr Amalia Gastaldelli

  136. Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas

    Article • JCI Insight, October 2019, American Society for Clinical Investigation

    Dr Amalia Gastaldelli

  137. Association of serum lipids with β-cell function in obese children and adolescents

    Article • Endocrine Connections, October 2019, Bioscientifica

    Dr Amalia Gastaldelli

  138. From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options

    Article • JHEP Reports, October 2019, Elsevier

    Dr Amalia Gastaldelli

  139. Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity

    Article • BJS, October 2019, Oxford University Press (OUP)

    Dr Amalia Gastaldelli

  140. 27th Annual Meeting of the European Group for the study of Insulin Resistance, Lisbon, Portugal, 8–9th May 2019

    Article • Cardiovascular Endocrinology & Metabolism, September 2019, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  141. Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus

    Article • International Journal of Molecular Sciences, August 2019, MDPI AG

    Dr Amalia Gastaldelli

  142. The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle glucose uptake

    Article • EBioMedicine, August 2019, Elsevier

    Dr Amalia Gastaldelli

  143. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD

    Article • Nutrition Metabolism and Cardiovascular Diseases, August 2019, Elsevier

    Dr Amalia Gastaldelli

  144. Insulin resistance, liver inflammation and fibrosis in patients with NAFLD

    Article • Journal of Hepatology, July 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Amalia Gastaldelli

  145. Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis

    Article • Nature Communications, June 2019, Springer Science + Business Media

    Dr Amalia Gastaldelli

  146. Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity

    Article • BJS, June 2019, Wiley

    Dr Amalia Gastaldelli

  147. 155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion

    Article • Diabetes, June 2019, American Diabetes Association

    Dr Amalia Gastaldelli

  148. 1888-P: Impaired Insulin Clearance Relates to Increased Liver Fat Content in Recent-Onset Type 2 Diabetes and to Impaired Glucose Control in Recent-Onset Type 1 Diabetes

    Article • Diabetes, June 2019, American Diabetes Association

    Dr Amalia Gastaldelli

  149. 245-OR: Glucose Production and Utilization following Oral Glucose Load in Type 2 Diabetes Patients Treated with Dapagliflozin Alone and in Saxagliptin Combination

    Article • Diabetes, June 2019, American Diabetes Association

    Dr Amalia Gastaldelli

  150. Osteoprotegerin as optimal target for the screening of patients with hepatocellular carcinoma at higher risk of mortality

    Article • Clinica Chimica Acta, June 2019, Elsevier

    Dr Amalia Gastaldelli

  151. Reduced insulin clearance relates to increased liver fat content in recent-onset type 2 diabetes and to impaired glucose control in recent-onset type 1 diabetes

    Article • Diabetologie und Stoffwechsel, May 2019, Thieme Publishing Group

    Dr Amalia Gastaldelli

  152. FRI-283-Impact on NAFLD of long-term weight loss after bariatric surgery

    Article • Journal of Hepatology, April 2019, Elsevier

    Dr Amalia Gastaldelli

  153. PS-006-MBOAT7 downregulation induces hepatic lipid accumulation

    Article • Journal of Hepatology, April 2019, Elsevier

    Dr Amalia Gastaldelli

  154. SAT-290-Association of liver inflammation and fibrosis score with noninvasive biomarkers in non-alcoholic fatty liver disease: Preliminary results from the MAST4HEALTH study

    Article • Journal of Hepatology, April 2019, Elsevier

    Dr Amalia Gastaldelli

  155. SAT-323-Selenoprotein P levels discriminate the degree of hepatic steatosis and are related to the NAS score in patients with non-alcoholic fatty liver disease

    Article • Journal of Hepatology, April 2019, Elsevier

    Dr Amalia Gastaldelli

  156. Role of vagal activation in postprandial glucose metabolism after gastric bypass in individuals with and without hypoglycaemia

    Article • Diabetes Obesity and Metabolism, March 2019, Wiley

    Dr Amalia Gastaldelli

  157. Beta-cell sensitivity to insulinotropic gut hormones is reduced after gastric bypass surgery

    Article • Gut, February 2019, BMJ

    Dr Amalia Gastaldelli

  158. Women-specific predictors of cardiovascular disease risk - new paradigms

    Article • International Journal of Cardiology, February 2019, Elsevier

    Dr Martino Deidda, Dr Amalia Gastaldelli

  159. Metabolomic profile of morbidly obese NAFLD: effect of weight loss by exenatide or diet

    Article • Digestive and Liver Disease, February 2019, Elsevier

    Dr Amalia Gastaldelli

  160. Selenoprotein P levels discriminate the degree of hepatic steatosis and are related to the NAS score in patients with non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, February 2019, Elsevier

    Dr Amalia Gastaldelli

  161. Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp.

    Article • PLoS ONE, December 2018, PLOS

    Dr Amalia Gastaldelli

  162. Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

    Article • BMC Gastroenterology, November 2018, Springer Science + Business Media

    Dr Amalia Gastaldelli

  163. Phthalates exposure as determinant of albuminuria in type 2 diabetes subjects: a cross-sectional study

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2018, Endocrine Society

    Dr Amalia Gastaldelli

  164. Interaction of GLP-1 and Ghrelin on Glucose Tolerance in Healthy Humans

    Article • Diabetes, July 2018, American Diabetes Association

    Dr Amalia Gastaldelli

  165. The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases

    Article • Environmental Science and Pollution Research, July 2018, Springer Science + Business Media

    Dr Amalia Gastaldelli

  166. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars

    Article • Diabetes Care, May 2018, American Diabetes Association

    Dr Amalia Gastaldelli

  167. Publisher Correction: Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery

    Article • Scientific Reports, May 2018, Springer Science + Business Media

    Dr Amalia Gastaldelli

  168. Beneficial Effects of RYGB on ß-Cell Function and Hepatic and Peripheral Insulin Sensitivity Are Maintained Seven Years after Surgery in Both Diabetic and Nondiabetic Subjects

    Article • Diabetes, May 2018, American Diabetes Association

    Dr Amalia Gastaldelli

  169. Lean Subjects with Fatty Liver Show Decreased GLP-1 and GIP Response during OGTT

    Article • Diabetes, May 2018, American Diabetes Association

    Dr Amalia Gastaldelli

  170. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2018, Endocrine Society

    Dr Amalia Gastaldelli

  171. Bile acid composition modulate insulin resistance in non-diabetic patients with NAFLD

    Article • Journal of Hepatology, April 2018, Elsevier

    Dr Amalia Gastaldelli

  172. Impact of short term weight loss (very low calorie diet vs bariatric surgery) on hepatic insulin resistance and plasma lipidomic profile

    Article • Journal of Hepatology, April 2018, Elsevier

    Dr Amalia Gastaldelli

  173. In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease

    Article • Journal of Hepatology, April 2018, Elsevier

    Dr Amalia Gastaldelli

  174. Predisposition to diabetes is related to insulin resistance in NAFLD patients and to decreased insulin secretion in HCV patients

    Article • Journal of Hepatology, April 2018, Elsevier

    Dr Amalia Gastaldelli

  175. Saturated fat is more metabolically harmful for the human liver than polyunsaturated fat or simple sugars

    Article • Journal of Hepatology, April 2018, Elsevier

    Dr Amalia Gastaldelli

  176. Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research

    Article • World Journal of Hepatology, February 2018, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Amalia Gastaldelli

  177. Vitamin D Supplementation in Patients With Type 2 Diabetes: The Vitamin D for Established Type 2 Diabetes (DDM2) Study

    Article • Journal of the Endocrine Society, February 2018, Endocrine Society

    Dr Amalia Gastaldelli

  178. Bile acid composition modulates insulin resistance in non-diabetic patients with NAFLD

    Article • Digestive and Liver Disease, February 2018, Elsevier

    Dr Amalia Gastaldelli

  179. Reply

    Article • Hepatology, January 2018, Wiley

    Dr Amalia Gastaldelli

  180. The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF

    Article • Scientific Reports, January 2018, Nature

    Dr Amalia Gastaldelli

  181. Beta-cell sensitivity to glucose is impaired after gastric bypass surgery

    Article • Diabetes Obesity and Metabolism, December 2017, Wiley

    Dr Amalia Gastaldelli

  182. Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD

    Article • Scientific Reports, December 2017, Springer Science + Business Media

    Dr Amalia Gastaldelli

  183. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance

    Article • Hepatology, November 2017, Wiley

    Dr Amalia Gastaldelli

  184. Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?

    Article • Clinical Science, November 2017, Portland Press Ltd.

    Dr Amalia Gastaldelli

  185. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up

    Article • Cytokine, November 2017, Elsevier

    Dr Amalia Gastaldelli

  186. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD

    Article • Scientific Reports, September 2017, Springer Science + Business Media

    Dr Amalia Gastaldelli

  187. Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes

    Article • Diabetes Care, August 2017, American Diabetes Association

    Dr Amalia Gastaldelli

  188. Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery

    Article • Scientific Reports, August 2017, Nature

    Dr Amalia Gastaldelli

  189. Correction

    Article • Hepatology, July 2017, Wiley

    Dr Amalia Gastaldelli

  190. The color of fat and its central role in the development and progression of metabolic diseases

    Article • Hormone Molecular Biology and Clinical Investigation, July 2017, De Gruyter

    Dr Amalia Gastaldelli

  191. Glucose kinetics

    Article • Current Opinion in Clinical Nutrition & Metabolic Care, July 2017, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  192. Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study

    Article • Diabetologia, June 2017, Springer Science + Business Media

    Dr Amalia Gastaldelli

  193. An extended fatty liver index to predict non-alcoholic fatty liver disease

    Article • Diabetes & Metabolism, June 2017, Elsevier

    Dr Amalia Gastaldelli

  194. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

    Article • Digestive and Liver Disease, May 2017, Elsevier

    Professor Amedeo LONARDO, Dr Amalia Gastaldelli

  195. Response to Comment on Gastaldelli et al. Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass. Diabetes Care 2016;39:1925–1931

    Article • Diabetes Care, March 2017, American Diabetes Association

    Dr Amalia Gastaldelli

  196. Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies

    Article • Journal of Hypertension, March 2017, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  197. Novel hepato-preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes

    Article • Diabetes Obesity and Metabolism, February 2017, Wiley

    Dr Amalia Gastaldelli

  198. Increased FNDC5/Irisin expression in human hepatocellular carcinoma

    Article • Peptides, February 2017, Elsevier

    Dr Amalia Gastaldelli

  199. Increased hepatic glucose production and insulin resistance are associated to increased plasma concentrations of glucogenic amino acids in subjects with NAFLD

    Article • Digestive and Liver Disease, February 2017, Elsevier

    Dr Amalia Gastaldelli

  200. The combination of mucus-degrading gram-negative bacteria and reduced antimicrobial peptides drives adipose tissue inflammation and NAFLD progression in mice lacking NLRP3-inflammasome

    Article • Digestive and Liver Disease, February 2017, Elsevier

    Dr Amalia Gastaldelli

  201. Hepatic Insulin Resistance and Altered Gluconeogenic Pathway in Premature Baboons

    Article • Endocrinology, January 2017, Endocrine Society

    Dr Amalia Gastaldelli, Giovanna Muscogiuri

  202. Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2017, Endocrine Society

    Dr Amalia Gastaldelli, Martina Hackl, Michael Krebs

  203. Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in non-diabetic, morbidly obese patients

    Article • Diabetes Obesity and Metabolism, January 2017, Wiley

    Dr Amalia Gastaldelli

  204. Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study

    Article • Diabetes, January 2017, American Diabetes Association

    Dr Amalia Gastaldelli

  205. Increased hepatic glucose production and insulin resistance in subjects with non-alcoholic fatty liver disease is associated to increased plasma concentrations of glucogenic amino acids

    Article • Journal of Hepatology, January 2017, Elsevier

    Dr Amalia Gastaldelli

  206. The combination of mucus-degrading gram-negative bacteria and reduced antimicrobial peptides drives adipose tissue inflammation and non-alcoholic fatty liver disease progression in mice lacking NLRP3-inflammasome

    Article • Journal of Hepatology, January 2017, Elsevier

    Dr Amalia Gastaldelli

  207. Response to: Drug therapy for ectopic fat: myth or reality?

    Article • Expert Review of Cardiovascular Therapy, December 2016, Taylor & Francis

    Dr Amalia Gastaldelli

  208. Pathophysiology of Non Alcoholic Fatty Liver Disease

    Article • International Journal of Molecular Sciences, December 2016, MDPI AG

    Dr Amalia Gastaldelli

  209. Ectopic fat: a target for cardiometabolic risk management

    Article • Expert Review of Cardiovascular Therapy, November 2016, Taylor & Francis

    Dr Amalia Gastaldelli

  210. Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study

    Article • Hepatology, November 2016, Wiley

    Dr Amalia Gastaldelli, Eugenio Cersosimo

  211. Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes

    Article • Trends in Endocrinology and Metabolism, October 2016, Elsevier

    Dr Amalia Gastaldelli

  212. Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass

    Article • Diabetes Care, August 2016, American Diabetes Association

    Dr Amalia Gastaldelli

  213. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

    Article • Journal of Hepatology, June 2016, Elsevier

    Dr Amalia Gastaldelli

  214. Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2016, Endocrine Society

    Dr Amalia Gastaldelli

  215. Glucose uptake saturation explains glucose kinetics profiles measured by different tests

    Article • AJP Endocrinology and Metabolism, May 2016, American Physiological Society

    Dr Amalia Gastaldelli

  216. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

    Article • Obesity Facts, April 2016, Karger Publishers

    Dr Amalia Gastaldelli

  217. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

    Article • Diabetologia, April 2016, Springer Science + Business Media

    Dr Amalia Gastaldelli

  218. Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

    Article • Nature Communications, February 2016, Nature

    Dr Amalia Gastaldelli

  219. Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial

    Article • Diabetes Obesity and Metabolism, February 2016, Wiley

    Dr Amalia Gastaldelli

  220. Time for Glucagon like peptide-1 receptor agonists treatment for patients with NAFLD?

    Article • Journal of Hepatology, February 2016, Elsevier

    Dr Amalia Gastaldelli

  221. Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, February 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Amalia Gastaldelli

  222. Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, February 2016, Elsevier

    Dr Amalia Gastaldelli

  223. Lack of NLRP3-inflammasome leads to gut-liver axis derangement and increases hepatic injury in a mouse model of NAFLD

    Article • Digestive and Liver Disease, February 2016, Elsevier

    Dr Amalia Gastaldelli

  224. Early effect of Roux-en-Y gastric bypass on insulin sensitivity and signaling

    Article • Surgery for Obesity and Related Diseases, January 2016, Elsevier

    Dr Amalia Gastaldelli

  225. Adipose Tissue Insulin Resistance is Associated with Macrophage Activation in Non-Diabetic Patients with Non-Alcoholic Fatty Liver Disease

    Article • Journal of Hepatology, January 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Amalia Gastaldelli

  226. Angiopoietin-Like4 is Associated with Lipid Metabolism and Severe Fibrosis in Non-Diabetic Patients with Non-Alcoholic Fatty Liver Disease

    Article • Journal of Hepatology, January 2016, Elsevier

    Dr Amalia Gastaldelli

  227. Evaluation of Metabolic Parameters of Hepatic Dysfunction in Subjects with Hepatocellular Carcinoma and their Change after Liver Transplantation: A Metabolomic Approach

    Article • Journal of Hepatology, January 2016, Elsevier

    Dr Amalia Gastaldelli

  228. Exenatide Exerts Its Positive Effects on Liver by Reducing both Hepatic and Adipose Tissue Insulin Resistance

    Article • Journal of Hepatology, January 2016, Elsevier

    Dr Amalia Gastaldelli

  229. Lack of NLRP3-Inflammasome Leads to Gut-Liver AXIS Derangement and Increases Hepatic Injury in a Mouse Model of Non-Alcoholic Fatty Liver Disease

    Article • Journal of Hepatology, January 2016, Elsevier

    Dr Amalia Gastaldelli

  230. Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

    Article • Hepatology, December 2015, Wiley

    Dr Amalia Gastaldelli

  231. The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis

    Article • Nutrients, November 2015, MDPI AG

    Dr Amalia Gastaldelli

  232. Brown versus white fat: are they really playing a role in obesity and cardiometabolic risk?

    Article • Clinical Lipidology, October 2015, Future Medicine

    Dr Amalia Gastaldelli

  233. Obesity and carotid artery remodeling

    Article • Nutrition and Diabetes, August 2015, Nature

    Dr Amalia Gastaldelli

  234. Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146TCF7L2Gene Variant

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2015, Endocrine Society

    Dr Amalia Gastaldelli

  235. Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System

    Article • Diabetes, June 2015, American Diabetes Association

    Dr Amalia Gastaldelli

  236. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms

    Article • Current Diabetes Reports, April 2015, Springer Science + Business Media

    Dr Amalia Gastaldelli

  237. P1042 : Deregulation of de novo lipogenesis can be associated with liver damage in patients with non alcoholic fatty liver disease

    Article • Journal of Hepatology, April 2015, Elsevier

    Dr Amalia Gastaldelli

  238. O064 : Gut-liver axis derangement due to lack of inflammasome activity leads to visceral obesity and nash development

    Article • Journal of Hepatology, April 2015, Elsevier

    Dr Amalia Gastaldelli

  239. P1056 : Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in patients with nonalcoholic fatty liver disease, independently of diabetes, hypertension and dyslipidemia

    Article • Journal of Hepatology, April 2015, Elsevier

    Dr Amalia Gastaldelli

  240. P0519 : Lipidomics reveals that low plasma unsaturated to saturated fat ratios are biomarkers of NAFLD and liver damage

    Article • Journal of Hepatology, April 2015, Elsevier

    Dr Amalia Gastaldelli

  241. Peripheral Insulin Resistance and Impaired Insulin Signaling Contribute to Abnormal Glucose Metabolism in Preterm Baboons

    Article • Endocrinology, March 2015, Endocrine Society

    Dr Amalia Gastaldelli

  242. Gut–liver axis derangement due to lack of inflammasome activity leads to visceral obesity and NASH development

    Article • Digestive and Liver Disease, February 2015, Elsevier

    Dr Amalia Gastaldelli

  243. Liver damage can be associated with deregulation of the de novo lipogenesis pathway in subjects with Non Alcoholic Fatty Liver Disease

    Article • Digestive and Liver Disease, February 2015, Elsevier

    Dr Amalia Gastaldelli

  244. The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal musclein vivo

    Article • Diabetic Medicine, January 2015, Wiley

    Dr Amalia Gastaldelli, Eugenio Cersosimo

  245. Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases

    Article • Hormone Molecular Biology and Clinical Investigation, January 2015, De Gruyter

    Dr Amalia Gastaldelli

  246. Neurophysiological and Behavioural Variables in Cognitive Impairment: Towards a Personalised Monitoring System

    Article • January 2015, Springer Science + Business Media

    Dr Amalia Gastaldelli

  247. Corrigendum to “Insulin resistance, adipose depots and gut: Interactions and pathological implications” [Dig. Liver Dis. 42 (2010) 310–319]

    Article • Digestive and Liver Disease, November 2014, Elsevier

    Dr Amalia Gastaldelli

  248. Risk Relationship between Insulin Resistance, Diabetes, and Atherosclerotic Cardiovascular Disease

    Article • October 2014, Taylor & Francis

    Dr Amalia Gastaldelli

  249. The Disposition Index Does Not Reflect β-Cell Function in IGT Subjects Treated With Pioglitazone

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2014, Endocrine Society

    Dr Amalia Gastaldelli

  250. The good and bad effects of statins on insulin sensitivity and secretion

    Article • Endocrine Research, September 2014, Taylor & Francis

    Dr Amalia Gastaldelli

  251. Effects of sitagliptin on ectopic fat contents and glucose metabolism in type 2 diabetic patients with fatty liver: A pilot study

    Article • Journal of Diabetes Investigation, August 2014, Wiley

    Dr Amalia Gastaldelli

  252. Pathophysiology of Prediabetes: Role of Lipotoxicity?

    Article • July 2014, World Scientific Pub Co Pte Lt

    Dr Amalia Gastaldelli

  253. Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women

    Article • Journal of Endocrinological Investigation, June 2014, Springer Science + Business Media

    Dr Amalia Gastaldelli

  254. Altered Islet Function and Insulin Clearance Cause Hyperinsulinemia in Gastric Bypass Patients With Symptoms of Postprandial Hypoglycemia

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2014, Endocrine Society

    Dr Amalia Gastaldelli

  255. Matched weight loss induced by sleeve gastrectomy or gastric bypass similarly improves metabolic function in obese subjects

    Article • Obesity, May 2014, Wiley

    Dr Amalia Gastaldelli

  256. HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH

    Article • PLoS ONE, May 2014, PLOS

    Dr Amalia Gastaldelli

  257. Evidence from a single individual that increased plasma GLP-1 and GLP-1-stimulated insulin secretion after gastric bypass are independent of foregut exclusion

    Article • Diabetologia, May 2014, Springer Science + Business Media

    Dr Amalia Gastaldelli

  258. Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance

    Article • PLoS ONE, April 2014, PLOS

    Dr Amalia Gastaldelli

  259. Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW

    Article • Diabetes Care, April 2014, American Diabetes Association

    Dr Amalia Gastaldelli

  260. P857 A NEW INDEX OF GLUTATHIONE TURNOVER (GSH_TI) AND ITS ASSOCIATION WITH SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

    Article • Journal of Hepatology, April 2014, Elsevier

    Dr Amalia Gastaldelli

  261. P843 ALTERATION IN GLUCOSE METABOLISM AFTER AN ORAL GLUCOSE LOAD AND RELATIONSHIP WITH LIVER DAMAGE IN PATIENTS WITH NAFLD

    Article • Journal of Hepatology, April 2014, Elsevier

    Dr Amalia Gastaldelli

  262. P840 ALTERATION IN LIPID METABOLISM AFTER AN ORAL FAT LOAD IN PATIENTS WITH NAFLD

    Article • Journal of Hepatology, April 2014, Elsevier

    Dr Amalia Gastaldelli

  263. P845 IMPACT OF FAT VERSUS GLUCOSE LOAD ON OXIDATIVE STRESS IN NON-ALCOHOLIC FATTY LIVER DISEASE

    Article • Journal of Hepatology, April 2014, Elsevier

    Dr Amalia Gastaldelli

  264. P849 QUANTITATIVE AND QUALITATIVE ANALYSIS OF PLASMA FREE FATTY ACIDS AND THEIR IMPACT ON LIVER DAMAGE IN NAFLD PATIENTS

    Article • Journal of Hepatology, April 2014, Elsevier

    Dr Amalia Gastaldelli

  265. Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic

    Article • Diabetologia, March 2014, Springer Science + Business Media

    Dr Amalia Gastaldelli

  266. Blockade of Glucagon-like Peptide 1 Receptor Corrects Postprandial Hypoglycemia After Gastric Bypass

    Article • Gastroenterology, March 2014, Elsevier

    Dr Amalia Gastaldelli

  267. Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, February 2014, Elsevier

    Dr Amalia Gastaldelli

  268. Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, February 2014, Elsevier

    Dr Amalia Gastaldelli

  269. Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, February 2014, Elsevier

    Dr Amalia Gastaldelli

  270. Visceral Adipose Tissue and Ectopic Fat Deposition

    Article • January 2014, Taylor & Francis

    Dr Amalia Gastaldelli

  271. Motor Activity in Aging: An Integrated Approach for Better Quality of Life

    Article • International Scholarly Research Notices, January 2014, Hindawi Publishing Corporation

    Dr Amalia Gastaldelli

  272. Albiglutide for the treatment of type 2 diabetes mellitus

    Article • January 2014, Prous Science

    Dr Amalia Gastaldelli

  273. Moving Medical Semeiotics to the Digital Realm - SEMEOTICONS Approach to Face Signs of Cardiometabolic Risk

    Article • January 2014, Scitepress

    Dr Amalia Gastaldelli

  274. Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk

    Article • Diabetes Care, September 2013, American Diabetes Association

    Dr Amalia Gastaldelli

  275. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes

    Article • Metabolism, September 2013, Elsevier

    Dr Amalia Gastaldelli

  276. Metabolic Consequences of Adipose Triglyceride Lipase Deficiency in Humans: An In Vivo Study in Patients With Neutral Lipid Storage Disease With Myopathy

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2013, Endocrine Society

    Dr Amalia Gastaldelli

  277. A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment

    Article • Diabetes Obesity and Metabolism, August 2013, Wiley

    Dr Amalia Gastaldelli

  278. Increased carotid intima-media thickness in the physiologic range is associated with impaired postprandial glucose metabolism, insulin resistance and beta cell dysfunction

    Article • Atherosclerosis, August 2013, Elsevier

    Dr Amalia Gastaldelli

  279. Ectopic fat: the true culprit linking obesity and cardiovascular disease?

    Article • Thrombosis and Haemostasis, July 2013, Schattauer GmbH

    Dr Amalia Gastaldelli

  280. Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT

    Article • July 2013, Bioscientifica

    Dr Marjan Alssema, Dr Amalia Gastaldelli

  281. Prevention of Diabetes With Pioglitazone in ACT NOW: Physiologic Correlates

    Article • Diabetes, July 2013, American Diabetes Association

    Dr Amalia Gastaldelli

  282. Long-Term Effects of Bariatric Surgery on Meal Disposal and  -Cell Function in Diabetic and Nondiabetic Patients

    Article • Diabetes, July 2013, American Diabetes Association

    Dr Amalia Gastaldelli

  283. Biliopancreatic Diversion in Nonobese Patients With Type 2 Diabetes: Impact and Mechanisms

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2013, Endocrine Society

    Dr Amalia Gastaldelli

  284. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study

    Article • Diabetologia, June 2013, Springer Science + Business Media

    Dr Amalia Gastaldelli

  285. Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

    Article • Nutrients, May 2013, MDPI AG

    Dr Amalia Gastaldelli

  286. The effect of chronic twice daily exenatide treatment on β‐cell function in new onset type 2 diabetes

    Article • Clinical Endocrinology, April 2013, Wiley

    Dr Amalia Gastaldelli

  287. 1351 CONTRIBUTION OF VISCERAL FAT AND HEPATIC FAT TO METABOLIC DERANGEMENTS AND LIVER DAMAGE IN NAFLD PATIENTS

    Article • Journal of Hepatology, April 2013, Elsevier

    Dr Amalia Gastaldelli

  288. 73 KR ÜPPEL LIKE FACTOR 6 (KLF6) PROTECTS FROM NAFLD PROGRESSION THROUGH REGULATION OF ADIPOSE TISSUE INSULIN RESISTANCE

    Article • Journal of Hepatology, April 2013, Elsevier

    Dr Amalia Gastaldelli

  289. 1365 METABOLIC ALTERATIONS OF LIPID KINETICS IN NAFLD PATIENTS AND THEIR CONTRIBUTION TO LIVER DAMAGE

    Article • Journal of Hepatology, April 2013, Elsevier

    Dr Amalia Gastaldelli

  290. Imaging cardiac fat

    Article • European Heart Journal - Cardiovascular Imaging, March 2013, European Society of Cardiology

    Dr Amalia Gastaldelli

  291. Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver

    Article • Diabetes Care, March 2013, American Diabetes Association

    Dr Amalia Gastaldelli

  292. Importance of liver fat indices for diagnosis of hepatic steatosis

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2013, Thieme Publishing Group

    Dr Amalia Gastaldelli

  293. Insulin Resistance and Endothelial Dysfunction: A Mutual Relationship in Cardiometabolic Risk

    Article • Current Pharmaceutical Design, March 2013, Bentham Science Publishers

    Dr Amalia Gastaldelli

  294. Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity

    Article • Diabetologia, January 2013, Springer Science + Business Media

    Dr Amalia Gastaldelli

  295. A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic Steatohepatitis

    Article • Journal of Diabetes & Metabolism, January 2013, OMICS Publishing Group

    Dr Amalia Gastaldelli

  296. Metabolic response to high-carbohydrate and low-carbohydrate meals in a nonhuman primate model

    Article • AJP Endocrinology and Metabolism, December 2012, American Physiological Society

    Dr Amalia Gastaldelli

  297. Gastric bypass and banding equally improve insulin sensitivity and β cell function

    Article • Journal of Clinical Investigation, November 2012, American Society for Clinical Investigation

    Dr Amalia Gastaldelli

  298. The role of cardiac fat in insulin resistance

    Article • Current Opinion in Clinical Nutrition & Metabolic Care, November 2012, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  299. Dynamics of Circulating Ligands and Soluble Receptor for Advanced Glycation End-Product in Liver Transplantation

    Article • Transplantation, November 2012, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  300. Dynamics of Circulating Ligands and Soluble Receptor for Advanced Glycation End-Product in Liver Transplantation

    Article • Transplantation, November 2012, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  301. Direct effect of GLP-1 infusion on endogenous glucose production in humans

    Article • Diabetologia, October 2012, Springer Science + Business Media

    Dr Amalia Gastaldelli

  302. Hepatic and Cardiac Steatosis

    Article • Heart Failure Clinics, October 2012, Elsevier

    Dr Amalia Gastaldelli

  303. Mechanisms for the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2012, Endocrine Society

    Dr Amalia Gastaldelli

  304. Effects of Adding Exercise to a 16-Week Very Low-Calorie Diet in Obese, Insulin-Dependent Type 2 Diabetes Mellitus Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2012, Endocrine Society

    Dr Amalia Gastaldelli

  305. The ontogeny of the endocrine pancreas in the fetal/newborn baboon

    Article • June 2012, Bioscientifica

    Dr Amalia Gastaldelli

  306. Integrated Physiology/Obesity

    Article • Diabetes, June 2012, American Diabetes Association

    Dr Amalia Gastaldelli

  307. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques

    Article • Hepatology, April 2012, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  308. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease

    Article • Diabetic Medicine, April 2012, Wiley

    Dr Amalia Gastaldelli

  309. 1310 PERIPHERAL INSULIN RESISTANCE RATHER THAN HEPATIC IS A PRIMARY DEFECT IN NON OBESE, NON DIABETIC, NON DYSLIPIDEMIC NAFLD PATIENTS: CORRELATION WITH LIVER DAMAGE

    Article • Journal of Hepatology, April 2012, Elsevier

    Dr Amalia Gastaldelli

  310. 1290 THE EFFECT OF EXERCISE ON THE METABOLIC AND HISTOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE

    Article • Journal of Hepatology, April 2012, Elsevier

    Dr Amalia Gastaldelli

  311. 215 THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (RAGE) AXIS IN LIVER TRANSPLANTATION

    Article • Journal of Hepatology, April 2012, Elsevier

    Dr Amalia Gastaldelli

  312. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

    Article • Hepatology, March 2012, Wiley

    Dr Amalia Gastaldelli

  313. Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models

    Article • Metabolism, March 2012, Elsevier

    Dr Amalia Gastaldelli, Professor Alexandra Kautzky-Willer

  314. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease

    Article • Hepatology, March 2012, Wiley

    Dr Amalia Gastaldelli

  315. Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes

    Article • PLoS ONE, February 2012, PLOS

    Dr Amalia Gastaldelli, Professor Alexandra Kautzky-Willer

  316. Relationship between fatty liver and glucose metabolism: A cross-sectional study in 571 obese children

    Article • Nutrition Metabolism and Cardiovascular Diseases, February 2012, Elsevier

    Dr Amalia Gastaldelli

  317. Diabetes and Nonalcoholic Fatty Liver Disease

    Article • Experimental Diabetes Research, January 2012, Hindawi Publishing Corporation

    Dr Amalia Gastaldelli

  318. Diet and Exercise in the Treatment of Fatty Liver

    Article • Journal of Nutrition and Metabolism, January 2012, Hindawi Publishing Corporation

    Dr Amalia Gastaldelli

  319. Coordinated Defects in Hepatic Long Chain Fatty Acid Metabolism and Triglyceride Accumulation Contribute to Insulin Resistance in Non-Human Primates

    Article • PLoS ONE, November 2011, PLOS

    Dr Amalia Gastaldelli

  320. Pericardial Rather Than Epicardial Fat is a Cardiometabolic Risk Marker: An MRI vs Echo Study

    Article • Journal of the American Society of Echocardiography, October 2011, Elsevier

    Dr Amalia Gastaldelli

  321. Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population

    Article • Journal of Internal Medicine, September 2011, Wiley

    Dr Amalia Gastaldelli

  322. Metabolic effects of muraglitazar in type 2 diabetic subjects

    Article • Diabetes Obesity and Metabolism, September 2011, Wiley

    Dr Amalia Gastaldelli

  323. Ectopic Fat Storage, Insulin Resistance, and Hypertension

    Article • Current Pharmaceutical Design, September 2011, Bentham Science Publishers

    Dr Amalia Gastaldelli

  324. Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans

    Article • Diabetes, August 2011, American Diabetes Association

    Dr Amalia Gastaldelli

  325. Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus

    Article • Diabetes Research and Clinical Practice, August 2011, Elsevier

    Dr Amalia Gastaldelli

  326. Protective role of adiponectin on endothelial dysfunction induced by AGEs: A clinical and experimental approach

    Article • Microvascular Research, July 2011, Elsevier

    Dr Amalia Gastaldelli

  327. Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2011, Endocrine Society

    Dr Amalia Gastaldelli

  328. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

    Article • Diabetologia, May 2011, Springer Science + Business Media

    Dr Amalia Gastaldelli

  329. What is the role of the receptor for advanced glycation end products-ligand axis in liver injury?

    Article • Liver Transplantation, May 2011, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  330. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans

    Article • American Journal of Clinical Nutrition, April 2011, American Society for Nutrition

    Dr Amalia Gastaldelli

  331. Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and Women

    Article • Diabetes, April 2011, American Diabetes Association

    Dr Amalia Gastaldelli

  332. Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention

    Article • Diabetes Care, April 2011, American Diabetes Association

    Dr Amalia Gastaldelli

  333. Pathophysiology of Prediabetes

    Article • Medical Clinics of North America, March 2011, Elsevier

    Dr Amalia Gastaldelli

  334. 1264 CRITICAL ROLE OF TRIGLYCERIDES AND LONG CHAIN FATTY ACYL COA ACCUMULATION IN LIVER INSULIN RESISTANCE IN THE BABOON. A NEW NON-HUMAN PRIMATE MODEL OF NAFLD

    Article • Journal of Hepatology, March 2011, Elsevier

    Dr Amalia Gastaldelli

  335. 842 PREDISPOSITION TO DEVELOP DIABETES IN SUBJECTS WITH NAFLD IS RELATED TO INSULIN RESISTANCE RATHER THAN TO DECREASED B-CELL FUNCTION

    Article • Journal of Hepatology, March 2011, Elsevier

    Dr Amalia Gastaldelli

  336. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis

    Article • Liver International, February 2011, Wiley

    Dr Amalia Gastaldelli

  337. Mechanism and Effects of Glucose Absorption during an Oral Glucose Tolerance Test Among Females and Males

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2011, Endocrine Society

    Dr Amalia Gastaldelli, Professor Alexandra Kautzky-Willer

  338. Ectopic fat and cardiovascular disease: What is the link?

    Article • Nutrition Metabolism and Cardiovascular Diseases, September 2010, Elsevier

    Dr Amalia Gastaldelli

  339. Effect of Oral Sebacic Acid on Postprandial Glycemia, Insulinemia, and Glucose Rate of Appearance in Type 2 Diabetes

    Article • Diabetes Care, August 2010, American Diabetes Association

    Dr Amalia Gastaldelli

  340. ORIGINAL ARTICLE: Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with Type 2 diabetes: a double tracer OGTT study

    Article • Clinical Endocrinology, August 2010, Wiley

    Dr Amalia Gastaldelli

  341. Impact of Tobacco Smoking on Lipid Metabolism, Body Weight and Cardiometabolic Risk

    Article • Current Pharmaceutical Design, August 2010, Bentham Science Publishers

    Dr Amalia Gastaldelli

  342. Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial

    Article • American Journal of Obstetrics and Gynecology, August 2010, Elsevier

    Dr Amalia Gastaldelli

  343. Pioglitazone in the treatment of NASH: the role of adiponectin

    Article • Alimentary Pharmacology & Therapeutics, July 2010, Wiley

    Dr Amalia Gastaldelli

  344. Fatty liver disease: the hepatic manifestation of metabolic syndrome

    Article • Hypertension Research, May 2010, Springer Science + Business Media

    Dr Amalia Gastaldelli

  345. Insulin resistance, adipose depots and gut: Interactions and pathological implications

    Article • Digestive and Liver Disease, May 2010, Elsevier

    Dr Amalia Gastaldelli

  346. 340 FATTY LIVER INDEX (FLI) IS AN INDEPENDENT PREDICTOR OF CHANGES IN METABOLIC AND CARDIOVASCULAR PARAMETERS: RESULTS FROM A 3-YEAR FOLLOW UP IN THE RISC STUDY

    Article • Journal of Hepatology, April 2010, Elsevier

    Dr Amalia Gastaldelli

  347. 82 KRUPPEL LIKE FACTOR 6 (KLF6) REGULATES HEAPTIC INSULIN RESISTANCE (HEP-IR)

    Article • Journal of Hepatology, April 2010, Elsevier

    Dr Amalia Gastaldelli

  348. Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

    Article • International Journal of Obesity, December 2009, Nature

    Dr Amalia Gastaldelli

  349. A new approach to study in vivo cellular metabolism using a modellistic analysis of magnetic resonance spectra

    Article • Mathematical Biosciences, November 2009, Elsevier

    Dr Amalia Gastaldelli

  350. Pancreatic islet amyloidosis, β-cell apoptosis, and α-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons

    Article • Proceedings of the National Academy of Sciences, August 2009, Proceedings of the National Academy of Sciences

    Dr Amalia Gastaldelli

  351. Reply:

    Article • Hepatology, July 2009, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  352. Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms

    Article • AJP Endocrinology and Metabolism, June 2009, American Physiological Society

    Dr Amalia Gastaldelli

  353. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis

    Article • Hepatology, June 2009, Wiley

    Dr Amalia Gastaldelli

  354. Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study

    Article • European Journal of Endocrinology, May 2009, Bioscientifica

    Dr Amalia Gastaldelli

  355. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients

    Article • AJP Endocrinology and Metabolism, May 2009, American Physiological Society

    Dr Amalia Gastaldelli

  356. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C

    Article • Hepatology, April 2009, Wiley

    Dr Amalia Gastaldelli

  357. Imaging and Laboratory Biomarkers in Cardiovascular Disease

    Article • Current Pharmaceutical Design, April 2009, Bentham Science Publishers

    Dr Amalia Gastaldelli

  358. The Effect of Menopause on Carotid Artery Remodeling, Insulin Sensitivity, and Plasma Adiponectin in Healthy Women

    Article • American Journal of Hypertension, April 2009, Oxford University Press (OUP)

    Dr Amalia Gastaldelli

  359. 346 INCREASED LIVER EXPRESSION OF INFLAMMATORY MEDIATORS IS ASSOCIATED WITH HEPATIC INSULIN RESISTANCE IN LEAN, NON-DIABETIC PATIENTS WITH CHRONIC HEPATITIS C

    Article • Journal of Hepatology, April 2009, Elsevier

    Dr Amalia Gastaldelli

  360. 55 METABOLIC AND ANTI-INFLAMMATORY BENEFICIAL EFFECTS OF PIOGLITAZONE (PIO) TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND THEIR ASSOCIATIONS WITH HISTOLOGICAL IMPROVEMENT

    Article • Journal of Hepatology, April 2009, Elsevier

    Dr Amalia Gastaldelli

  361. Accurate segmentation of subcutaneous and intermuscular adipose tissue from MR images of the thigh

    Article • Journal of Magnetic Resonance Imaging, February 2009, Wiley

    Dr Amalia Gastaldelli

  362. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice

    Article • Journal of Lipid Research, February 2009, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Amalia Gastaldelli

  363. Hepatic fat is not associated with β-cell function or postprandial free fatty acid response

    Article • Metabolism, February 2009, Elsevier

    Dr Amalia Gastaldelli

  364. Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats

    Article • Hypertension, January 2009, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  365. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

    Article • Hepatology, January 2009, Wiley

    Dr Amalia Gastaldelli

  366. Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons.

    Article • Cardiovascular Diabetology, January 2009, Springer Science + Business Media

    Dr Amalia Gastaldelli

  367. The Crosstalk Between Insulin and Renin-Angiotensin-Aldosterone Signaling Systems and its Effect on Glucose Metabolism and Diabetes Prevention

    Article • Current Vascular Pharmacology, October 2008, Bentham Science Publishers

    Dr Amalia Gastaldelli

  368. Elevated Concentrations of Liver Enzymes and Ferritin Identify a New Phenotype of Insulin Resistance: Effect of Weight Loss After Gastric Banding

    Article • Obesity Surgery, September 2008, Springer Science + Business Media

    Dr Amalia Gastaldelli

  369. Automatic correction of intensity inhomogeneities improves unsupervised assessment of abdominal fat by MRI

    Article • Journal of Magnetic Resonance Imaging, August 2008, Wiley

    Dr Amalia Gastaldelli

  370. Abdominal fat: does it predict the development of type 2 diabetes?

    Article • American Journal of Clinical Nutrition, May 2008, Oxford University Press (OUP)

    Dr Amalia Gastaldelli

  371. Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk

    Article • European Heart Journal Supplements, March 2008, Oxford University Press (OUP)

    Dr Amalia Gastaldelli

  372. Model-based assessment of insulin sensitivity of glucose disposal and endogenous glucose production from double-tracer oral glucose tolerance test

    Article • Computer Methods and Programs in Biomedicine, February 2008, Elsevier

    Dr Amalia Gastaldelli

  373. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis

    Article • Trends in Molecular Medicine, February 2008, Elsevier

    Dr Amalia Gastaldelli

  374. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects

    Article • European Heart Journal, January 2008, European Society of Cardiology

    Dr Amalia Gastaldelli

  375. Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat

    Article • Hypertension, January 2008, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  376. 36 FATTY LIVER INDEX IS ASSOCIATED WITH INCREASED INSULIN RESISTANCE AND CAROTID INTIMA MEDIA THICKNESS (IMT) IN NONDIABETIC SUBJECTS: THE RISC STUDY

    Article • Journal of Hepatology, January 2008, Elsevier

    Dr Amalia Gastaldelli

  377. Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients

    Article • Diabetes, December 2007, American Diabetes Association

    Dr Amalia Gastaldelli

  378. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

    Article • Hepatology, December 2007, Wiley

    Dr Amalia Gastaldelli, Dr Riccardo Dalle Grave

  379. Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients

    Article • Diabetologia, December 2007, Springer Science + Business Media

    Dr Amalia Gastaldelli

  380. Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women

    Article • Fertility and Sterility, December 2007, Elsevier

    Dr Amalia Gastaldelli

  381. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy

    Article • AJP Heart and Circulatory Physiology, October 2007, American Physiological Society

    Dr Amalia Gastaldelli

  382. Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis

    Article • Journal of Hepatology, October 2007, Elsevier

    Dr Amalia Gastaldelli

  383. Insulin Resistance, Insulin Response, and Obesity as Indicators of Metabolic Risk

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2007, Endocrine Society

    Dr Amalia Gastaldelli

  384. Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects

    Article • Gastroenterology, August 2007, Elsevier

    Dr Amalia Gastaldelli

  385. Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training

    Article • Diabetologia, March 2007, Springer Science + Business Media

    Dr Amalia Gastaldelli

  386. Reduction in Hematocrit and Hemoglobin Following Pioglitazone Treatment is not Hemodilutional in Type II Diabetes Mellitus

    Article • Clinical Pharmacology & Therapeutics, March 2007, Nature

    Dr Amalia Gastaldelli

  387. Effect of Pioglitazone on the Metabolic and Hormonal Response to a Mixed Meal in Type II Diabetes

    Article • Clinical Pharmacology & Therapeutics, February 2007, Nature

    Dr Amalia Gastaldelli

  388. Quantification of Liver Glucose Metabolism by Positron Emission Tomography: Validation Study in Pigs

    Article • Gastroenterology, February 2007, Elsevier

    Dr Amalia Gastaldelli

  389. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes

    Article • AJP Endocrinology and Metabolism, January 2007, American Physiological Society

    Dr Amalia Gastaldelli

  390. A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2006, New England Journal of Medicine (NEJM/MMS)

    Dr Amalia Gastaldelli

  391. Circulating Soluble Receptor for Advanced Glycation End Products Is Inversely Associated with Glycemic Control and S100A12 Protein

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2006, Endocrine Society

    Dr Amalia Gastaldelli

  392. Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea

    Article • Diabetes Care, October 2006, American Diabetes Association

    Dr Amalia Gastaldelli

  393. Thiazolidinediones improve beta-cell function in type 2 diabetic patients

    Article • AJP Endocrinology and Metabolism, October 2006, American Physiological Society

    Dr Amalia Gastaldelli

  394. The Effect of Pioglitazone on the Liver: Role of adiponectin

    Article • Diabetes Care, September 2006, American Diabetes Association

    Dr Amalia Gastaldelli

  395. O-210

    Article • Fertility and Sterility, September 2006, Elsevier

    Dr Amalia Gastaldelli

  396. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome

    Article • Clinical Pharmacology & Therapeutics, August 2006, Nature

    Dr Amalia Gastaldelli

  397. [11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia

    Article • Nuclear Medicine and Biology, May 2006, Elsevier

    Dr Amalia Gastaldelli

  398. The Effect of Rosiglitazone on the Liver: Decreased Gluconeogenesis in Patients with Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2006, Endocrine Society

    Dr Amalia Gastaldelli

  399. Pathogenesis and Clinical Features of Obesity and Insulin Resistance

    Article • Immunology Endocrine & Metabolic Agents - Medicinal Chemistry, February 2006, Bentham Science Publishers

    Dr Amalia Gastaldelli

  400. ANALYSIS OF DOUBLE-TRACER GLUCOSE KINETICS IN HUMANS DURING ORAL GLUCOSE TOLERANCE TEST

    Article • IFAC Proceedings Volumes, January 2006, Elsevier

    Dr Amalia Gastaldelli

  401. Visceral fat and beta cell function in non-diabetic humans

    Article • Diabetologia, August 2005, Springer Science + Business Media

    Dr Amalia Gastaldelli

  402.  -Cell Function in Morbidly Obese Subjects During Free Living: Long-Term Effects of Weight Loss

    Article • Diabetes, July 2005, American Diabetes Association

    Dr Amalia Gastaldelli

  403. Plasma Adiponectin in Nonalcoholic Fatty Liver Is Related to Hepatic Insulin Resistance and Hepatic Fat Content, Not to Liver Disease Severity

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2005, Endocrine Society

    Dr Amalia Gastaldelli

  404.  -Cell Function in Mild Type 2 Diabetic Patients: Effects of 6-month glucose lowering with nateglinide

    Article • Diabetes Care, April 2005, American Diabetes Association

    Dr Amalia Gastaldelli

  405. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

    Article • Diabetologia, March 2005, Springer Science + Business Media

    Dr Amalia Gastaldelli

  406. β-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2005, Endocrine Society

    Dr Amalia Gastaldelli

  407. Beta-Cell Function in Obesity: Effects of Weight Loss

    Article • Diabetes, November 2004, American Diabetes Association

    Dr Amalia Gastaldelli

  408. Characterization of  -cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests

    Article • AJP Endocrinology and Metabolism, October 2004, American Physiological Society

    Dr Amalia Gastaldelli

  409. re: Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47:31?39

    Article • Diabetologia, August 2004, Springer Science + Business Media

    Dr Amalia Gastaldelli

  410. Reply to Comment on: Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 43:31?39

    Article • Diabetologia, August 2004, Springer Science + Business Media

    Dr Amalia Gastaldelli

  411. Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2004, Endocrine Society

    Dr Amalia Gastaldelli

  412. Visceral Fat in Hypertension: Influence on Insulin Resistance and  -Cell Function

    Article • Hypertension, July 2004, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  413. Vascular Effects of Improving Metabolic Control With Metformin or Rosiglitazone in Type 2 Diabetes

    Article • Diabetes Care, May 2004, American Diabetes Association

    Dr Amalia Gastaldelli

  414. An accurate and robust method for unsupervised assessment of abdominal fat by MRI

    Article • Journal of Magnetic Resonance Imaging, January 2004, Wiley

    Dr Amalia Gastaldelli

  415. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

    Article • Diabetologia, January 2004, Springer Science + Business Media

    Dr Amalia Gastaldelli

  416. 60 Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and HCV chronic hepatitis

    Article • Journal of Hepatology, January 2004, Elsevier

    Dr Amalia Gastaldelli

  417. A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes

    Article • Diabetes, September 2003, American Diabetes Association

    Dr Amalia Gastaldelli

  418. Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance

    Article • Diabetologia, September 2003, Springer Science + Business Media

    Dr Amalia Gastaldelli

  419. Influence of Ethnicity and Familial Diabetes on Glucose Tolerance and Insulin Action: A Physiological Analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2003, Endocrine Society

    Dr Amalia Gastaldelli

  420. Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects

    Article • AJP Endocrinology and Metabolism, December 2002, American Physiological Society

    Dr Amalia Gastaldelli

  421. Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2002, Endocrine Society

    Dr Amalia Gastaldelli

  422. Assessing Insulin Secretion by Modeling in Multiple-Meal Tests: Role of Potentiation

    Article • Diabetes, February 2002, American Diabetes Association

    Dr Amalia Gastaldelli

  423. Effect of Acute Hyperglycemia on Insulin Secretion in Humans

    Article • Diabetes, February 2002, American Diabetes Association

    Dr Amalia Gastaldelli

  424. Determination of the Enrichment of the Hydrogen Bound to Carbon 5 of Glucose on 2H2O Administration

    Article • Analytical Biochemistry, October 2001, Elsevier

    Dr Amalia Gastaldelli

  425. Effect of Physiological Hyperinsulinemia on Gluconeogenesis in Nondiabetic Subjects and in Type 2 Diabetic Patients

    Article • Diabetes, August 2001, American Diabetes Association

    Dr Amalia Gastaldelli

  426. A model for assessing insulin secretion and its control under free-living conditions

    Article • Diabetes, February 2001, American Diabetes Association

    Dr Amalia Gastaldelli

  427. A model for glucose control of insulin secretion during 24 h of free living.

    Article • Diabetes, February 2001, American Diabetes Association

    Dr Amalia Gastaldelli

  428. Hyperinsulinemia and Autonomic Nervous System Dysfunction in Obesity

    Article • Circulation, January 2001, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  429. Insulin prolongs the QTc interval in humans

    Article • AJP Regulatory Integrative and Comparative Physiology, December 2000, American Physiological Society

    Dr Amalia Gastaldelli

  430. Determinants of postabsorptive endogenous glucose output in non-diabetic subjects

    Article • Diabetologia, October 2000, Springer Science + Business Media

    Dr Amalia Gastaldelli

  431. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.

    Article • Diabetes, August 2000, American Diabetes Association

    Dr Amalia Gastaldelli

  432. Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach

    Article • AJP Endocrinology and Metabolism, May 2000, American Physiological Society

    Dr Amalia Gastaldelli

  433. A Model for Assessing Insulin Secretion Function During a 24 Hour Standardized Life Period

    Article • IFAC Proceedings Volumes, March 2000, Elsevier

    Dr Amalia Gastaldelli

  434. Fat metabolism during high-intensity exercise in endurance-trained and untrained men

    Article • Metabolism, January 2000, Elsevier

    Dr Amalia Gastaldelli

  435. Modelling Interpretation of the Kinetics of Metabolic Processes

    Article • January 2000, Springer Science + Business Media

    Dr Amalia Gastaldelli

  436. Assessment of methods for improving tracer estimation of non-steady-state rate of appearance

    Article • Journal of Applied Physiology, November 1999, American Physiological Society

    Dr Amalia Gastaldelli

  437. Insulin: new roles for an ancient hormone

    Article • European Journal of Clinical Investigation, October 1999, Wiley

    Dr Amalia Gastaldelli, Professor Fabio Monzani

  438. A modellistic view of the kinetics of metabolic processes: differences in the glucose and xylose degradation pathway

    Article • Chemical Physics Letters, August 1999, Elsevier

    Dr Amalia Gastaldelli

  439. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency

    Article • Diabetes, June 1999, American Diabetes Association

    Dr Amalia Gastaldelli

  440. Linear and Nonlinear Properties of Heart Rate Variability: Influence of Obesity

    Article • Annals of the New York Academy of Sciences, June 1999, Wiley

    Dr Amalia Gastaldelli

  441. Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans

    Article • Diabetes, May 1999, American Diabetes Association

    Dr Amalia Gastaldelli

  442. Autonomic and Hemodynamic Responses to Insulin in Lean and Obese Humans

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1998, Endocrine Society

    Dr Amalia Gastaldelli

  443. Influence of duration of obesity on the insulin resistance of obese non-diabetic patients

    Article • International Journal of Obesity, March 1998, Springer Science + Business Media

    Dr Amalia Gastaldelli

  444. Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes

    Article • Clinical Pharmacology & Therapeutics, August 1997, Nature

    Dr Amalia Gastaldelli

  445. Regulation of glucose production during exercise at 80% of VO2peak in untrained humans

    Article • AJP Endocrinology and Metabolism, August 1997, American Physiological Society

    Dr Amalia Gastaldelli

  446. Energy expenditure of swimmers during high volume training

    Article • Medicine & Science in Sports & Exercise, July 1997, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  447. Glucose kinetics in interstitial fluid can be predicted by compartmental modeling

    Article • AJP Endocrinology and Metabolism, March 1997, American Physiological Society

    Dr Amalia Gastaldelli

  448. Kinetic Analysis and Comparison of Models of Xylose Metabolism byKlebsiella planticola

    Article • Biochemical and Biophysical Research Communications, October 1996, Elsevier

    Dr Amalia Gastaldelli

  449. Modeling Interpretation of Microbe Metabolism Detected by Nuclear Magnetic Resonance

    Article • Biochemical and Biophysical Research Communications, October 1996, Elsevier

    Dr Amalia Gastaldelli

  450. Effect of theophylline on substrate metabolism during exercise

    Article • Metabolism, September 1996, Elsevier

    Dr Amalia Gastaldelli

  451. Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise

    Article • Diabetes, September 1995, American Diabetes Association

    Dr Amalia Gastaldelli

  452. Lipid and Carbohydrate Metabolism in IDDM During Moderate and Intense Exercise

    Article • Diabetes, September 1995, American Diabetes Association

    Dr Amalia Gastaldelli

  453. Pathway of free fatty acid oxidation in human subjects. Implications for tracer studies.

    Article • Journal of Clinical Investigation, January 1995, American Society for Clinical Investigation

    Dr Amalia Gastaldelli

  454. Protein synthesis and breakdown in skin and muscle: a leg model of amino acid kinetics

    Article • AJP Endocrinology and Metabolism, September 1994, American Physiological Society

    Dr Amalia Gastaldelli

  455. 850 PATHWAY OF PLASMA FFA OXIDATION DURING EXERCISE

    Article • Medicine & Science in Sports & Exercise, May 1994, Wolters Kluwer Health

    Dr Amalia Gastaldelli

  456. A Leg Model of Amino Acid Kinetics in Skin and Muscle

    Article • IFAC Proceedings Volumes, March 1994, Elsevier

    Dr Amalia Gastaldelli

  457. Changes in Tracer Infusion Rates to Minimize the Structure Error in the Steele’s Model

    Article • IFAC Proceedings Volumes, March 1994, Elsevier

    Dr Amalia Gastaldelli

  458. An Energy Model for the Description of a Metabolic Process

    Article • IFAC Proceedings Volumes, March 1994, Elsevier

    Dr Amalia Gastaldelli

  459. Pathway of Free Fatty Acid Oxidation

    Article • IFAC Proceedings Volumes, March 1994, Elsevier

    Dr Amalia Gastaldelli

  460. Ross

    Article • Bloomsbury Academic

    Dr Amalia Gastaldelli